Novel Biomarkers in Chronic Airway Diseases

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2009 by Chonbuk National University.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Chonbuk National University

ClinicalTrials.gov Identifier:

NCT00849836

First received: February 23, 2009

Last updated: NA

Last verified: February 2009

History: No changes posted

Tracking Information

First Received Date ^ICMJE

February 23, 2009

Last Updated Date

February 23, 2009

Start Date ^ICMJE

February 2009

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Novel Biomarkers in Chronic Airway Diseases

Official Title ^ICMJE

The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

Brief Summary

The purpose of this study is:

To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case Control
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Probability Sample

Study Population

Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

Condition ^ICMJE

Asthma
COPD

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Acute exacerbation
Stable disease
Healthy control

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Estimated Completion Date

January 2010

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

> 18 years olds
Both sexes
Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: So Ri Kim, MD, PhD	82-63-250-2475	sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD	82-63-250-1664	leeyc@chonbuk.ac.kr

Location Countries ^ICMJE

Korea, Republic of

Administrative Information

NCT Number ^ICMJE

NCT00849836

Other Study ID Numbers ^ICMJE

RCPD

Has Data Monitoring Committee

Not Provided

Responsible Party

Yong Chul Lee, Chonbuk National University Medical School

Study Sponsor ^ICMJE

Chonbuk National University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Not Provided

Information Provided By

Chonbuk National University

Verification Date

February 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top